hlm006474 and Skin-Neoplasms

hlm006474 has been researched along with Skin-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for hlm006474 and Skin-Neoplasms

Article	Year
E2F1/IGF-1R Loop Contributes to BRAF Inhibitor Resistance in Melanoma. The Journal of investigative dermatology, 2020, Volume: 140, Issue:6 Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cell Line, Tumor; Drug Resistance, Neoplasm; E2F1 Transcription Factor; Feedback, Physiological; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Hydroxyquinolines; Melanoma; Promoter Regions, Genetic; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Receptor, IGF Type 1; Skin; Skin Neoplasms	2020

Article

Year

E2F1/IGF-1R Loop Contributes to BRAF Inhibitor Resistance in Melanoma.

The Journal of investigative dermatology, 2020, Volume: 140, Issue:6

Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cell Line, Tumor; Drug Resistance, Neoplasm; E2F1 Transcription Factor; Feedback, Physiological; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Hydroxyquinolines; Melanoma; Promoter Regions, Genetic; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Receptor, IGF Type 1; Skin; Skin Neoplasms

2020